Symbol="ACIU"
AssetType="Common Stock"
Name="AC Immune Ltd"
Description="AC Immune SA, a clinical-stage biopharmaceutical company, discovers, designs and develops drugs and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. The company is headquartered in Lausanne, Switzerland."
CIK="1651625"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="EPFL INNOVATION PARK, BUILDING B, 1015 LAUSANNE, CH"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="241405000"
EBITDA="-67819000"
PERatio="None"
PEGRatio="0"
BookValue="1.829"
DividendPerShare="0"
DividendYield="0"
EPS="-0.93"
RevenuePerShareTTM="0.047"
ProfitMargin="0"
OperatingMarginTTM="-17.68"
ReturnOnAssetsTTM="-0.215"
ReturnOnEquityTTM="-0.378"
RevenueTTM="3935000"
GrossProfitTTM="-56401000"
DilutedEPSTTM="-0.93"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.098"
AnalystTargetPrice="10.35"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="44.1"
PriceToBookRatio="0.908"
EVToRevenue="9.37"
EVToEBITDA="-0.524"
Beta="0.674"
num_52WeekHigh="3.83"
num_52WeekLow="1.68"
num_50DayMovingAverage="2.498"
num_200DayMovingAverage="2.398"
SharesOutstanding="83531000"
DividendDate="None"
ExDividendDate="None"
symbol="ACIU"
open="2.93"
high="2.93"
low="2.80"
price="2.82"
volume="72729.00"
latest_trading_day="2023-07-27"
previous_close="2.87"
change="-0.05"
change_percent="-1.7422%"
aroon_positive_momentum_days="60"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="60"
Volume_recent_avg="661455"
Change_recent_avg="0.01"
Delta_recent_avg="0.16"
Variance_recent_avg="0.08"
Change_ratio_recent_avg="-0.17"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="60"
Aroon_momentum_negative="40"
image_negative_thumbnail_id_1="504"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0101.jpeg"
image_negative_thumbnail_id_2="498"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0107.jpeg"
image_neutral_thumbnail_id_1="574"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0025.jpeg"
image_neutral_thumbnail_id_2="522"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0077.jpeg"
image_positive_thumbnail_id_1="978"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0140.jpeg"
image_positive_thumbnail_id_2="649"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0059.jpeg"
image_professor_thumbnail_id_1="1202"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
image_professor_thumbnail_id_2="1180"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0014.jpeg"
